B

$BIIB

3 articles found
2 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

Biogen Class Action Certified: Securities Lawsuit Over 2021 Misrepresentation Claims

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.
BIIBclass actionfederal securities laws
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

ALS Therapeutics Market Poised to More Than Double by 2035

ALS therapeutics market to more than double by 2035, reaching $1.96 billion. Growth driven by genetic therapies, improved diagnostics, and disease awareness.
CYTKBIIBIONSAMLXrare diseasegene therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Alzheimer's Therapeutics Market Set to Exceed $6B by 2026 Amid Rising Investment

Alzheimer's therapeutics market projected to exceed $6B by 2026 driven by rising disease prevalence and increased pharma investment in disease-modifying treatments.
ABBVLLYNVORHHBYBIIBmarket growthAlzheimer's disease